Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 58,524 shares at $4.76 ($279K) on 2019-12-10, disclosed to the SEC on 2019-12-11.
Open-market sale of $279k ATRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2019-12-11 | $1.4M | — | Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |